Thanks Wildaisy for going right to the source.
Here is some information that I posted on the PR Forum regarding what I have learned about several of these studies. Please note the information I am posting was not obtained directly from the individuals who are heading up these studies.http://forums.phoenixrising.me/showthread.php?11518-MONTOYA-STUDY-needs-more-participants&p=254197#post254197Lipkin Pathogen Gene Expression Study and Lipkin NIH Study
"If you participated in one of the recent CFS/ME studies you can contact the research center where the testing was conducted and ask if they can provide you with a current status update on the study(s).
Here is my understanding of the current estimate for completion of the Stanford/Lipkin gene expression/pathogen study. Testing is currently underway and the earliest the study is slated to be completed is June. Individual participants will receive a written report with their own test results. However, the report may not be in a format that can be easily interpreted. Therefore, some additional assistance will probably be offered to help with interpretaton of these results.
The NIH study, overseen by Dr. Lipkin, has completed the
collection of all the required samples and testing has begun. Estimated time for completion of the study is in 2012. Publication of the final results of the study will probably take about one year from the date the study is completed. Participants will not receive individual test results from this study.
The information provided above is my personal understanding of the current status of these two studies. Based on my past involvement with research studies, the dates given for completion and publication of a study are always estimates and often seem to be more like a moving target. "Valcyte Study
"It is my understanding that the second Valcyte study paper is currently undergoing a review process in preparation for submission for publication. "
(Note the cross-out is my own correction to the original posting. Unfortunately, my typing and proofreading skills are suffering along with the rest of my cognitive shortcomings.